Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2003
05/15/2003CA2466517A1 .omega.-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists
05/15/2003CA2466516A1 Targeting the reverse mode of the na+/ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy
05/15/2003CA2466432A1 Intraluminal device with a coating containing a therapeutic agent
05/15/2003CA2466425A1 Photodynamic therapy for the treatment of hair loss
05/15/2003CA2466391A1 Polyamide modulators of cox2 transcription
05/15/2003CA2466375A1 Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
05/15/2003CA2466336A1 Anti-muscarinic agent and estrogen-agonist for treating unstable or overactive bladder
05/15/2003CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/15/2003CA2466278A1 Rehydrating formulation
05/15/2003CA2466145A1 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466106A1 Methods of treating endometreosis
05/15/2003CA2466083A1 Compositions for the treatment of infectious diseases
05/15/2003CA2466081A1 Methods of reversing and preventing cardiovascular pathologies
05/15/2003CA2466061A1 Oral adhering and dissolving disc made by deposition with licorice extract
05/15/2003CA2466033A1 Method of treating disorder related to high cholesterol concentration
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2465952A1 Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
05/15/2003CA2465948A1 A method for treating inflammatory bowel disease
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465916A1 Treatment of breast cancer
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465886A1 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003CA2465869A1 Antimnemonic therapy for hypermemory syndromes
05/15/2003CA2465862A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
05/15/2003CA2465756A1 Compositions containing oils having a specific gravity higher than the specific gravity of water
05/15/2003CA2465744A1 Use of endothelin receptor antagonists in the treatment of tumour diseases
05/15/2003CA2465713A1 Derivatives of phenoxy-n-'4-(1,1-dioxoisothiazolidin-2-yl)phenyl!-valeramide and other compounds as inhibitors of coagulation factor xa for the treatment of thromboembolic diseases and tumours
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465680A1 Piperazine derivatives having sst1 antagonistic activity
05/15/2003CA2465499A1 Compositions and methods for treating osteoporosis
05/15/2003CA2465496A1 Oral controlled release forms useful for reducing or preventing nicotine cravings
05/15/2003CA2465491A1 Mitotic kinesin inhibitors
05/15/2003CA2465420A1 Anhydrous crystal form of valaciclovir hydrochloride
05/15/2003CA2465416A1 Amine salts of an integrin receptor antagonist
05/15/2003CA2465364A1 Pharmaceutical composition comprising an adenosine a1/a2 agonist and a sodium hydrogen exchanger inhibitor
05/15/2003CA2465189A1 Substituted diphenyl heterocycles useful for treating hcv infection
05/15/2003CA2465186A1 Methods for treating depression and other cns disorders using enantiomerically enriched desmethyl- and didesmethyl-metabolites of citalopram
05/15/2003CA2465159A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003CA2465110A1 Tamsulosin tablets
05/15/2003CA2465100A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2465068A1 Quinazoline derivatives as antitumor agents
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464763A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, medicinal compositions containing the same, medicinal use thereof and intermediates in the production thereof
05/15/2003CA2464757A1 Selective antibacterial agents
05/15/2003CA2464756A1 Method for the formation of ibuprofen crystals
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/15/2003CA2464626A1 Method for the in vitro synthesis of short double stranded rnas
05/15/2003CA2464531A1 Soluble cd40l(cd154) as a prognostic marker of atherosclerotic diseases
05/15/2003CA2464529A1 Method of treating estrogen responsive breast cancer
05/15/2003CA2464528A1 Pharmaceutical composition
05/15/2003CA2464217A1 Antimuscarinic aerosol
05/15/2003CA2464145A1 Polymorphic form of rimonabant, method for preparing it and pharmaceutical compositions containing it
05/15/2003CA2464007A1 Methods for treating ocular neovascular diseases
05/15/2003CA2462502A1 Improved use of antitumoral compound in cancer therapy
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003CA2462158A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
05/15/2003CA2461373A1 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination
05/15/2003CA2461183A1 Use of tyrosine kinase inhibitors for whitening human skin and treating melanocyte dysfunction associated diseases
05/15/2003CA2459745A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity
05/14/2003EP1310799A1 In vitro screening for ligands of the estrogen receptor
05/14/2003EP1310797A2 Method of monitoring neuroprotective treatment
05/14/2003EP1310555A2 Oligonucleotide modulation of protein kinase C
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310509A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
05/14/2003EP1310508A2 Estrogen sulfamate sulphatase inhibitors
05/14/2003EP1310507A2 Novel peptide nucleic acids
05/14/2003EP1310502A1 Phosphonocephem compound
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310495A2 Glycidyl amines and their use in the preparation of HIV protease inhibitors
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310488A1 Fused bicyclic amide compounds and medicinal use thereof
05/14/2003EP1310482A1 Prodrugs of excitatory amino acids
05/14/2003EP1310259A2 Formulation comprising a biphosphonate and an absorption enhancing agent for the treatment of osteoporosis
05/14/2003EP1310258A1 Enantiomers of steroids for the enhancement of memory and cognitive function
05/14/2003EP1310257A2 Hormonal contraceptive combination
05/14/2003EP1310256A2 Use of prostaglandin A or its derivatives for the treatment of psoriasis
05/14/2003EP1310255A1 Antipruritic agent
05/14/2003EP1310254A1 Medicinal compositions containing camptothecin derivative and ph regulating agent
05/14/2003EP1310253A1 Niacin-containing sustained-release tablets and kits
05/14/2003EP1310252A1 Injections
05/14/2003EP1310251A1 Antipruritic agent
05/14/2003EP1310250A1 Use of the compound 2-methoxyphenyl-1-methyl-5P-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an antiinflammatory drug with prevention of gastric hypersecretion and renal impairment
05/14/2003EP1310249A1 Use of polyunsatured fatty acids for the primary prevention of major cardiovascular events
05/14/2003EP1310248A1 Pharmaceutical composition
05/14/2003EP1310247A1 (+)-ephedrine as a sympathomimetic drug
05/14/2003EP1310246A2 Use of bronopol for the treatment of diseases in fish
05/14/2003EP1310245A1 Clopidogrel bisulfate tablet formulation
05/14/2003EP1310244A2 Compositions comprising an anticancer agent and a polyether block copolymer
05/14/2003EP1310243A1 Novel formulation
05/14/2003EP1310239A1 Cosmetical and dermatological sunscreen compositions containing hydroxybenzophenones and pentasodium ethylenediamine tetramethylenephosphonate
05/14/2003EP1309726A2 Rna sequence-specific mediators of rna interference
05/14/2003EP1309721A2 Modulating multiple lineage kinase proteins
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309704A2 Regulation of human membrane-type serine protease
05/14/2003EP1309699A2 Elongase genes and uses thereof
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
1 ... 5469 5470 5471 5472 5473 5474 5475 5476 5477 5478 5479 5480 5481 5482 5483 5484 5485 5486 5487 5488 5489 ... 7860